PSTI Pluristem Therapeutics, Inc.

+0.02  (1%)
Previous Close 1.38
Open 1.41
Price To book 3.73
Market Cap 134.86M
Shares 96,331,000
Volume 43,097
Short Ratio 2.87
Av. Daily Volume 317,868

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 enrollment to commence 1H 2017.
PLX-PAD (stem cells)
Critical limb ischemia (CLI)
Phase 2 put on clinical hold Jun 2013. Lifted Sept 2013. Enrollment completed May 2016. Data are due late 2017.
PLX-PAD (stem cells)
Intermittent claudication, or IC